| Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline |
99 |
| Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline |
32 |
| Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease |
27 |
| Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients |
22 |
| Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer |
13 |
| Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline |
12 |
| Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline |
10 |
| Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018 |
9 |
| Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings |
9 |
| Stereotactic body radiation therapy (SBRT) for high-risk prostate cancer: Where are we now? |
9 |
| Common error pathways seen in the RO-ILS data that demonstrate opportunities for improving treatment safety |
9 |
| Development and Implementation of a Simulation-Based Educational Workshop on Gynecological Brachytherapy: Pilot Study at a National Meeting |
9 |
| Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: An ASTRO Consensus Paper |
8 |
| Stereotactic radiosurgery for multiple brain metastases: Results of multicenter benchmark planning studies |
8 |
| Intrapatient study comparing 3D printed bolus versus standard vinyl gel sheet bolus for postmastectomy chest wall, radiation therapy |
8 |
| Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study |
8 |
| Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial |
8 |
| Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field |
7 |
| Reirradiation of thoracic cancers with intensity modulated proton therapy |
7 |
| Burnout and Resiliency in Canadian Oncology Residents: A Nationwide Resident and Program Director Survey |
7 |
| Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors |
7 |
| ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer |
7 |
| Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies |
6 |
| Toward consensus reporting of radiation-induced liver toxicity in the treatment of primary liver malignancies: Defining clinically relevant endpoints |
6 |
| Use of 5-alpha-reductase inhibitors as alternatives to luteinizing-hormone releasing hormone (LHRH) analogs or anti-androgens for prostate downsizing before brachytherapy |
5 |
| Liver reirradiation for patients with hepatocellutar carcinoma and liver metastasis |
5 |
| Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma |
5 |
| Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy |
5 |
| Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors |
5 |
| Incidence and Patterns of Locoregional Failure After Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma |
5 |
| Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus-Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center |
5 |
| One-Year Cosmesis and Fibrosis From ACCEL: Accelerated Partial Breast Irradiation (APBI) Using 27 Gy in 5 Daily Fractions |
5 |
| Why Smart Oncology Clinicians do Dumb Things: A Review of Cognitive Bias in Radiation Oncology |
5 |
| Personalized automated treatment planning for breast plus locoregional lymph nodes using Hybrid RapidArc |
5 |
| Safety of Prostate Stereotactic Body Radiation Therapy after Transurethral Resection of Prostate (TURP): A Propensity Score Matched Pair Analysis |
5 |
| Effects of Postmastectomy Radiation Therapy on Immediate Tissue Expander and Acellular Dermal Matrix Reconstruction: Results of a Prospective Clinical Trial |
4 |
| A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life |
4 |
| Collision Risk Mitigation of Varian TrueBeam Linear Accelerator With Supplemental Live-View Cameras |
4 |
| Analysis of Local Control and Pain Control After Spine Stereotactic Radiosurgery Reveals Inferior Outcomes for Hepatocellular Carcinoma Compared With Other Radioresistant Histologies |
4 |
| Radiation Oncologists' Role in End-of-Life Care: A Perspective From Medical Oncologists |
4 |
| An interactive contouring module improves engagement and interest in radiation oncology among preclinical medical students: Results of a randomized trial |
4 |
| Robustness Analysis for External Beam Radiation Therapy Treatment Plans: Describing Uncertainty Scenarios and Reporting Their Dosimetric Consequences |
4 |
| The impact of imaging modality (CT vs MRI) and patient position (supine vs prone) on tangential whole breast radiation therapy planning |
4 |
| Five-field IMRT class solutions and dosimetric planning guidelines for implementing accelerated partial breast irradiation |
4 |
| A Burnout Reduction and Wellness Strategy: Personal Financial Health for the Medical Trainee and Early Career Radiation Oncologist |
4 |
| Resource requirements and reduction in cardiac mortality from deep inspiration breath hold (DIBH) radiation therapy for left sided breast cancer patients: A prospective service development analysis |
4 |
| Stereotactic body radiation therapy for stage I non-small cell lung cancer: The importance of treatment planning algorithm and evaluation of a tumor control probability model |
4 |
| Three-Dimensional Bioabsorbable Tissue Marker Placement is Associated with Decreased Tumor Bed Volume Among Patients Receiving Radiation Therapy for Breast Cancer |
4 |
| Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery |
4 |
| Standardization of nodal radiation therapy through changes to a breast cancer clinical pathway throughout a large, integrated cancer center network |
4 |
